| Literature DB >> 34083549 |
Amaryllis Mavragani1, Konstantinos Gkillas2.
Abstract
Due to the COVID-19 pandemic originating in China in December 2019, apart from the grave concerns on the exponentially increasing casualties, the affected countries are called to deal with severe repercussions in all aspects of everyday life, from economic recession to national and international movement restrictions. Several regions managed to handle the pandemic more successfully than others in terms of life loss, while ongoing heated debates as to the right course of action for battling COVID-19 have divided the academic community as well as public opinion. To this direction, in this paper, an autoregressive COVID-19 prediction model with heterogeneous explanatory variables for Greece is proposed, taking past COVID-19 data, non-pharmaceutical interventions (NPIs), and Google query data as independent variables, from the day of the first confirmed case-February 26th-to the day before the announcement for the quarantine measures' softening-April 24th. The analysis indicates that the early measures taken by the Greek officials positively affected the flattening of the epidemic curve, with Greece having recorded significantly decreased COVID-19 casualties per million population and managing to stay on the low side of the deaths over cases spectrum. In specific, the prediction model identifies the 7-day lag that is needed in order for the measures' results to actually show, i.e., the optimal time-intervention framework for managing the disease's spread, while our analysis also indicates an appropriate point during the disease spread where restrictive measures should be applied. Present results have significant implications for effective policy making and in the designing of the NPIs, as the second wave of COVID-19 is expected in fall 2020, and such multidisciplinary analyses are crucial in order to understand the evolution of the Daily Deaths to Daily Cases ratio along with its determinants as soon as possible, for the assessment of the respective domestic health authorities' policy interventions as well as for the timely health resources allocation.Entities:
Mesh:
Year: 2021 PMID: 34083549 PMCID: PMC8175358 DOI: 10.1038/s41598-021-90293-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Cumulative worldwide COVID-19 (a) cases and (b) deaths (Chartsbin[22]).
Figure 2Total COVID-19 (a) cases and (b) deaths per million population in Europe (Chartsbin[22]).
Adopted measures considered in developing the NPIs variable.
| Description | Date |
|---|---|
| Closing of schools and universities | March 11 |
| Complete regional lockdown in two villages in Kozani | March 12 |
| Closing of cafes, bars, and restaurants | March 14 |
| Closing of retail and gyms | March 18 |
| Special forms and SMS for commuting | March 23 |
| Flight restrictions to and from certain countries | March 24 |
| Strict regional lockdown in two municipalities | March 31 |
| Strict lockdowns in certain regions | April 21 |
Descriptions of the dependent and independent variables for the daily deaths/daily cases model.
| Variable | Description |
|---|---|
| Daily deaths to daily cases ratio | |
| Deaths to cases ratioa | |
| Active cases to recovered cases ratiob | |
| Google trends | |
| Dummy for restrictive measures |
aRefers to total deaths and total cases.
bRefers to total active cases and total recovered cases.
Descriptions of the variables for the daily cases model.
| Variable | Description |
|---|---|
| Daily cases | |
| Active cases | |
| Recovered cases | |
| Dummy for restrictive measures |
Descriptions of variables for the daily deaths model.
| Variable | Description |
|---|---|
| Daily deaths | |
| Active cases | |
| Recovered cases | |
| Daily cases | |
| Dummy for restrictive measures |
Figure 3Cumulative COVID-19 (a) cases and (b) deaths in Greece as of May 3rd (Mapcharts [23]).
Figure 4(a) Daily cases; (b) daily deaths; (c) deaths to cases ratio; (d) active to recovered ratio, (e) cumulative cases and deaths; (f) cumulative active cases and recovered; (g) Google Trends time series.
Figure 5Official COVID-19 data vs. forecasts.
Heterogeneous autoregressive model with explanatory variables for the daily deaths to daily cases ratio.
| Variable | Coefficient | Std. error | t-statistic | Prob |
|---|---|---|---|---|
| c | 0.030732*** | (0.009801) | 3.135473 | [0.0033] |
| − 0.711290*** | (0.198599) | − 3.581536 | [0.0009] | |
| 3.829134*** | (0.536053) | 7.143197 | [0.0000] | |
| 2.509127*** | (0.736212) | 3.408159 | [0.0015] | |
| − 0.003312* | (0.001755) | − 1.887019 | [0.0666] | |
| − 0.035046** | (0.017100) | − 2.049438 | [0.0472] | |
| 0.320404*** | (0.101509) | 3.156401 | [0.0031] | |
| 0.056718 | (0.098270) | 0.577167 | [0.5671] | |
| Adjusted R-squared | 0.597701 | |||
| Akaike information criterion | − 3.329188 | |||
| Predicted R-squared | 0.429347 | |||
***, **, and * denote statistical significance at 1%, 5%, and 10%, respectively. Bootstrapped coefficient estimates and standard errors via 2000 repetitions. The final optimal number of days (w) are selected according to the Akaike information criterion. The variance inflation factor (VIF) is used in order to deal with multicollinearity issues among the regressors. Regressors with values of VIF higher than 5 are excluded from the estimation analysis.
Heterogeneous autoregressive model with explanatory variables for daily cases.
| Variable | Coefficient | Std. error | t-statistic | Prob |
|---|---|---|---|---|
| c | − 1.267733*** | 0.242387 | − 5.230209 | [0.0000] |
| 0.419785*** | 0.128818 | 3.258743 | [0.0021] | |
| 0.441888*** | 0.134237 | 3.291861 | [0.0019] | |
| − 0.368988*** | 0.121696 | − 3.032048 | [0.0040] | |
| − 0.557040* | 0.293529 | − 1.897736 | [0.0640] | |
| − 0.212671 | 0.131631 | − 1.615656 | [0.1130] | |
| Adjusted R-squared | 0.456847 | |||
| Akaike information criterion | 2.275832 | |||
| Predicted R-squared | 0.426791 | |||
***, **, and * denote statistical significance at 1%, 5%, and 10%, respectively. Bootstrapped coefficient estimates and standard errors via 2000 repetitions. The final optimal number of days (w) are selected according to the Akaike information criterion. The variance inflation factor (VIF) is used in order to deal with multicollinearity issues among the regressors. Regressors with values of VIF higher than 5 are excluded from the estimation analysis. The variable is divided by its full-sample standard deviation, estimated based on the basic formula of the variable’s standard deviation. Therefore, the inherent variability of each variable is moved, and all variables have a standard deviation of 1.
Heterogeneous autoregressive model with explanatory variables for daily deaths.
| Variable | Coefficient | Std. error | t-statistic | Prob |
|---|---|---|---|---|
| C | − 1.452676*** | 0.348555 | − 4.167708 | [0.0002] |
| − 0.706318*** | 0.151053 | − 4.675970 | [0.0000] | |
| − 0.713220*** | 0.155345 | − 4.591198 | [0.0000] | |
| 0.710464*** | 0.147018 | 4.832483 | [0.0000] | |
| − 0.678648*** | 0.309613 | − 2.191926 | [0.0348] | |
| − 0.273855* | 0.137364 | − 1.993650 | [0.0536] | |
| − 0.392670*** | 0.143116 | − 2.743717 | [0.0093] | |
| Adjusted R-squared | 0.424141 | |||
| Akaike information criterion | 2.332387 | |||
| Predicted R-squared | 0.502857 | |||
***, **, and * denote statistical significance at 1%, 5%, and 10%, respectively. Bootstrapped coefficient estimates and standard errors via 2000 repetitions. The final optimal number of days (w) and () are selected according to the Akaike information criterion. The variance inflation factor (VIF) is used in order to deal with multicollinearity issues among the regressors. Regressors with values of VIF higher than 5 are excluded from the estimation analysis. The variable is divided by its full-sample standard deviation, estimated based on the basic formula of the variable’s standard deviation. Therefore, the inherent variability of each variable is moved, and all variables have a standard deviation of 1.
Figure 6Official COVID-19 data on (a) daily cases vs. forecasts and (b) daily deaths vs. forecasts.
Figure 7Timeline of COVID-19 in Greece.